2024 DHA CPC: Menopause and Female Sexual Dysfunction

October 30, 2024

Target Audience

This activity provides continuing education for pharmacists and pharmacy technicians. A certificate of attendance is available for other attendees.

Learning Objectives

  1. Review female reproductive life cycle.
  2. Describe the role of the provider in treatment of genitourinary syndrome of menopause (GSM) and vulvovaginal atrophy (VVA).
  3. Review therapies available for treatment of GSM and VVA.
  4. Outline current guidelines for treatment of menopause symptoms.
  5. Review pharmacotherapy treatments for female sexual dysfunction.
Course summary
Available credit: 
  • 1.00 Pharmacists (ACPE)
    JA4008136-0000-24-194-L01-P
    No valid paper/electronic statement of credit will be offered. DHA, J-7, CEPO is accredited by the American Council for Pharmacy Education (ACPE) to provide continuing education for Pharmacists. This knowledge based activity will provide a maximum of 1.00 contact hours of pharmacy continuing education credit. Participant CE records will be electronically communicated to CPE Monitor. There is no cost to participate in this activity.
  • 1.00 Pharmacy Technicians (ACPE)
    JA4008136-0000-24-194-L01-T

    No valid paper/electronic statement of credit will be offered. DHA, J-7, CEPO is accredited by the American Council for Pharmacy Education (ACPE) to provide continuing education for Pharmacy Technicians. This knowledge based activity will provide a maximum of 1.00 contact hours of pharmacy continuing education credit. Participant CE records will be electronically communicated to CPE Monitor. There is no cost to participate in this activity.

  • 1.00 Certificate of Attendance
Course opens: 
10/21/2024
Course expires: 
11/14/2024
Event starts: 
10/30/2024 - 12:00pm EDT
Event ends: 
10/30/2024 - 1:00pm EDT

Sarah Abel, Pharm.D., M.S.C.P., C.C.S. Presenter has no financial or non-financial relationships to disclose.

Disclosure: DHA J-7 staff, Planning Committee Members and reviewers have no financial or non-financial interest to disclose. All faculty members have no financial or non-financial interest to disclose.

Available Credit

  • 1.00 Pharmacists (ACPE)
    JA4008136-0000-24-194-L01-P
    No valid paper/electronic statement of credit will be offered. DHA, J-7, CEPO is accredited by the American Council for Pharmacy Education (ACPE) to provide continuing education for Pharmacists. This knowledge based activity will provide a maximum of 1.00 contact hours of pharmacy continuing education credit. Participant CE records will be electronically communicated to CPE Monitor. There is no cost to participate in this activity.
  • 1.00 Pharmacy Technicians (ACPE)
    JA4008136-0000-24-194-L01-T

    No valid paper/electronic statement of credit will be offered. DHA, J-7, CEPO is accredited by the American Council for Pharmacy Education (ACPE) to provide continuing education for Pharmacy Technicians. This knowledge based activity will provide a maximum of 1.00 contact hours of pharmacy continuing education credit. Participant CE records will be electronically communicated to CPE Monitor. There is no cost to participate in this activity.

  • 1.00 Certificate of Attendance
Please login or create an account to take this course.


Access Codes: Some courses require an access code to register. Please reach out to the point of contact at the organization providing the activity for the registration code. The Continuing Education Program Office (CEPO) does not provide access codes.

Accommodations: CEPO provides captions and transcripts to hearing-impaired learners upon request. For real-time closed captioning, contact CEPO at least three (3) business days before the event. If we cannot arrange for live captioning, a video recording and audio transcript will be provided after the event, typically within ten business days. For events delivered by CEPO’s partners, please contact the course instructor to inquire about accommodations.

For more details, or to submit a request, email [email protected].